This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
Mus musculus
In vitro/In vivo
In vitro
In vivo
By sample type
Breast cancer cells (MDA-MB-231)
Mammary gland cells (MCF10A)
Mammary gland cells (NMuMG)
Plasma
Serum
By sample status
72 hr culture
Electroporated with Dicer antibody
Normal
Normal_Exiqon
Transplant islets into mouse xenotransplantation-rejected
shDicer-transfected
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-1262
MIMAT0005914
2.9e-2
5.0e-1
Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
4.3e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
6.2e-2
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
8.3e-3
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
3.9e-5
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
6.5e-5
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
0.0e+0
2.3e-1
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.
MIPF0000595_1
9
/
0
/
9
hsa-miR-1262
MIMAT0005914
1.0e-3
1.0e-3
Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.
MIPF0000595_1
9
/
0
/
9
[1]